Direct evidence of endothelial injury during cardiopulmonay bypass by demonstration of circulating endothelial cells

Perfusion

Volumn 21, Issue 3, 2006, Pages 133-137

  Schmid, Franz Xaver ^a   Floerchinger, Bernhard ^a   Vudattu, Nalini Kumar ^a   Eissner, Günther ^a   Haubitz, Marion ^b   Holler, Ernst ^a   Andreesen, Reinhard ^a   Birnbaum, Dietrich E ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CELL ACTIVATION; CELL COUNT; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HEART EJECTION FRACTION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VOLUNTEER;

AGED; ANGINA PECTORIS; CARDIOPULMONARY BYPASS; CELL SEPARATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; SURGICAL PROCEDURES, ELECTIVE;

EID: 33745396304     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659106pf860oa     Document Type: Article

References (15)

1. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008-16.
2. Menasche P, Haydur S, Paynet J et al. A potential mechanism of vasodilation after heart surgery: the temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994; 107: 293-99.
3. Eikemo H, Sellevold OFM, Videm V. Markers for endothelial activation during open heart surgery. Ann Thorac Surg 2004; 77: 214-19.
4. Woywodt A, Streiber F, De Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small vessel vasculitis. Lancet 2003; 361: 206-10.
5. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000; 65: 215-20.
6. Van Mourik JA, Boertjes R, Huisveld IA et al. Von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94: 179-85.
7. Lo B, Fijnheer R, Castigliego D et al. Activation of haemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass. Anesth Analg 2004; 99: 634-40.
8. Royston D. Blood cell activation. Sem Thorac Cardiovasc Surg 1990; 2/4: 341-57.
9. Chong AY, Blann AD, Lip GY. Assessment of endothelial damage and dysfunction: observations in relation to heart failure. Q J Med 2003; 96: 253-67.
10. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
11. Andresen TK, Svennevig JL, Videm V. Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass. Perfusion 2002; 17: 15-21.
12. Boyle EM, Pohlman TH, Johnson MC et al. The systemic inflammatory response. Ann Thorac Surg 1997; 64: S31-37.
13. Makin AJ, Blann AD, Chung NAY et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J 2004; 25: 371-76.
14. Mutin M, Canavy I, Blann A, Bory M, Sampol J. Evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulation endothelial cells. Blood 1999; 93: 2951-58.
15. Blann AD. Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis 2000; 11: 623-30.